{
    "medicine_id": "187ee2d82be384577e44056775a9c924ef385361",
    "platform_id": "DB04919",
    "metadata": {
        "name": "Zeftera Powder for solution",
        "composition": "Alfimeprase",
        "clinical_particulars": {
            "therapeutic_indications": "Alfimeprase is being evaluated as a potential treatment for acute ischemic stroke catheter occlusion CO and acute peripheral arterial occlusion PAO",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Alfimeprase is a recombinant direct acting fibrinolytic rDAF or blood clot dissolver that has the potential to rapidly and directly degrade fibrin a protein that provides the scaffolding for blood clots when delivered through a catheter to the site of a blood clot",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}